Home
About
Parents & Families
Clinicians
Researchers
Data and Sample Resources
Collaboration Opportunities
News
Contact us
Donate
Login
About
Parents & Families
Clinicians
Researchers
Data and Sample Resources
Collaboration Opportunities
News
Support
Funding Partners
Login
Donate
About
Parents & Families
Clinicians
Researchers
Data and Sample Resources
Collaboration Opportunities
News
Support
Funding Partners
Login
Donate
Login
News
Recent
Articles
Precision medicine now available to all ...
Wednesday, 20th Dec 23
ZERO enrols 1000th child – a milestone...
Thursday, 6th Jul 23
Zero Childhood Cancer precision medicine...
Wednesday, 15th Feb 23
ZERO National Symposium 2022 - Day 2 Pre...
Tuesday, 7th Feb 23
ZERO National Symposium 2022 - Day 1 Pre...
Tuesday, 7th Feb 23
New partnership set to speed up data ana...
Wednesday, 16th Nov 22
Inaugural ZERO symposium brings together...
Monday, 7th Nov 22
Professor Michelle Haber elected to dist...
Thursday, 26th May 22
ACRF Launches Liquid Biopsy Program for ...
Wednesday, 11th May 22
Improving the chances for children with ...
Monday, 20th Dec 21
High-tech partnership to help more kids ...
Wednesday, 15th Sep 21
New DNA-based test on the horizon for ch...
Monday, 13th Sep 21
Zero Childhood Cancer to continue its mi...
Wednesday, 14th Jul 21
Opening the black box of childhood cance...
Tuesday, 6th Oct 20
Professor Michelle Haber AM addresses la...
Saturday, 20th Jun 20
$67m Funding Collaboration: All Australi...
Thursday, 30th Apr 20
Zero Childhood Cancer continues fight to...
Wednesday, 29th Apr 20
Minderoo Foundation's $5 million donatio...
Tuesday, 14th May 19
'Zero Childhood Cancer' Clinical Trial D...
Saturday, 1st Sep 18
Children's Cancer Institute's Michelle H...
Wednesday, 25th Jul 18
Next >
Follow Us!
Authors
All authors
Tags
All topics
agrf
australian genome research facility
zero childhood cancer
childhood cancer
medicine program
zero
young australians
cancer research
expansion
cancer
media release
liquid biopsy
news
michelle haber
award
symposium
presentations
glenn marshall
david ziegler
personalised medicine
preclinical testing
partnership
data
genomics